• PDF: Delivered by email usually within 4 to 8 UK business hours.
  • PRINT/CD-ROM: Despatched within 1 to 2 working days.

UK Pharmaceutical Products Market Development Report

  • Publication Date:September 2005
  • Publisher:MBD Ltd
  • Product Type: Report
  • Pages:86

UK Pharmaceutical Products Market Development Report

The UK pharmaceutical market and industry is analysed in this report, covering end user markets for prescription medicines and over the counter products as well as the apparent UK markets for basic pharmaceuticals and pharmaceutical preparations. Market trends are fully detailed, including appraisal of demographic factors, NHS expenditure trends, generic drug activity and outsourcing and the impact of PPRS.

The report contains five year historical data, current market conditions and influences, together with a five year sector forecast by MBD analysts. The data is clearly presented and illustrated.

  • 1. Executive Summary
  • 2. Introduction
    • 2.1 Definitions
    • 2.2 Abbreviations
    • 2.3 Market Positioning
    • 2.4 UK Economy
    • 2.5 Market Factors
  • 3. Market Size and Trends
    • 3.1 Chapter Summary
    • 3.2 Market Size
    • 3.3 Market Segmentation
      • 3.3.1 Prescription Medicines
      • 3.3.2 Otc Medicines
    • 3.4 Market Trends
      • 3.4.1 Demographics
      • 3.4.2 Expenditure
      • 3.4.3 Distribution
      • 3.4.4 Generics
      • 3.4.5 Outsourcing
      • 3.4.6 Parallel Trade
      • 3.4.7 Herbal Medicines
  • 4. Supply Sources
    • 4.1 Chapter Summary
    • 4.2 Production
      • 4.2.1 Overview
      • 4.2.2 Segmentation
    • 4.3 Imports
      • 4.3.1 Overview
      • 4.3.2 Segmentation
    • 4.4 Exports
      • 4.4.1 Overview
      • 4.4.2 Segmentation
    • 4.5 Trade Surplus/Deficit
  • 5. Industry Structure
    • 5.1 Chapter Summary
    • 5.2 Industry Development
    • 5.3 Structure by Employment
    • 5.4 Structure by Turnover
    • 5.5 Company Profiles
      • 5.5.1 Astrazeneca
      • 5.5.2 Bristol-Myers Squibb Pharmaceuticals
      • 5.5.3 Celltech Group
      • 5.5.4 Eli Lilly & Co
      • 5.5.5 Ge Healthcare
      • 5.5.6 Glaxosmithkline
      • 5.5.7 Johnson & Johnson Medical
      • 5.5.8 Merck Sharp & Dohme
      • 5.5.9 Novartis UK
      • 5.5.10 Pfizer
      • 5.5.11 Pharmacia
      • 5.5.12 Roche Products
      • 5.5.13 Shire Pharmaceuticals Group
      • 5.5.14 Unichem
      • 5.5.15 3m Health Care
  • 6. Forecast
    • 6.1 Chapter Summary
    • 6.2 Market Size
    • 6.3 Market Segmentation
    • 6.4 Industry
  • 7. Further Sources & Contacts
    • 7.1 Trade Associations
    • 7.2 Trade Magazines
    • 7.3 Trade Exhibitions
  • List of Tables
    • 1 UK Apparent Consumption for Pharmaceutical Products, 2001-2005
    • 2: UK Market for Pharmaceutical Products, 2001-2005
    • 3: Segmentation of UK Apparent Consumption of Pharmaceutical Products, 2001-2005
    • 4: Segmentation of The UK Market for Pharmaceutical Products, 2001-2005
    • 5: Segmentation of The UK Market for Pharmaceutical Products, 2001-2005
    • 6: Number of Prescription Items Dispensed in The UK Market, by Country, 2000-2004
    • 7: Prescription Items Dispensed in England & Scotland, by Disease, 2004
    • 8: UK Market for Otc Pharmaceutical Products and Top Branded Sellers, by Therapeutic Category, 2005
    • 9: UK Population, by Age Group, 1981-2021
    • 10: Nhs Expenditure on Medicines in The UK, 2000-2004
    • 11: Nhs Pharmacies in England and Wales, 2000-2004
    • 12: UK Production of Pharmaceutical Products, 2001-2005
    • 13: Segmentation of The UK Production of Pharmaceutical Products, by Type, 2001-2005
    • 14: UK Imports of Pharmaceutical Products, 2001-2005
    • 15: Segmentation of UK Imports of Pharmaceutical Products, by Type, 2001-2005
    • 16: UK Exports of Pharmaceutical Products, 2001-2005
    • 17: Segmentation of UK Exports of Pharmaceutical Products, by Type, 2001-2005
    • 18: Analysis of The Changes in The Structure of The Basic Pharmaceuticals Manufacturing Industry, 2001-2005
    • 19: Analysis of The Changes in The Structure of The Pharmaceutical Preparations Manufacturing Industry, 2001-2005
    • 20: Analysis of The Employment Structure of The Basic Pharmaceuticals Manufacturing Industry, 2004 and 2005
    • 21: Analysis of The Employment Structure of The Pharmaceutical Preparations Manufacturing Industry, 2004 and 2005
    • 22: Analysis of The Financial Structure of The Basic Pharmaceuticals Manufacturing Sector, 2004 and 2005
    • 23: Analysis of The Financial Structure of The Pharmaceutical Preparations Manufacturing Sector, 2004 and 2005
    • 24: Financial Analysis of Astrazeneca, 2000-2004
    • 25: Key Financial Ratios for Astrazeneca, 2000-2004
    • 26: Financial Analysis of Bristol-Myers Squibb Pharmaceuticals, 2000-2004
    • 27: Key Financial Ratios for Bristol-Myers Squibb Pharmaceuticals, 2000-2004
    • 28: Financial Analysis of Celltech Group, 1999-2003
    • 29: Key Financial Ratios for Celltech Group, 1999-2003
    • 30: Financial Analysis of Eli Lilly & Company, 1999-2003
    • 31: Key Financial Ratios for Eli Lilly & Company, 1999-2003
    • 32: Financial Analysis of Ge Healthcare, 1999-2003
    • 33: Key Financial Ratios for Ge Healthcare, 1999-2003
    • 34: Financial Analysis of Glaxosmithkline, 2000-2004
    • 35: Key Financial Ratios for Glaxosmithkline, 2000-2004
    • 36: Financial Analysis of Johnson & Johnson Medical, 1999-2003
    • 37: Key Financial Ratios for Johnson & Johnson Medical, 1999-2003
    • 38: Financial Analysis of Merck Sharp & Dohme, 1999-2003
    • 39: Key Financial Ratios for Merck Sharp & Dome, 1999-2003
    • 40: Financial Analysis of Novartis UK, 2000-2004
    • 41: Key Financial Ratios for Novartis UK, 2000-2004
    • 42: Financial Analysis of Pfizer, 2000-2004
    • 43: Key Financial Ratios for Pfizer, 2000-2004
    • 44: Financial Analysis of Pharmacia, 2000-2004
    • 45: Key Financial Ratios for Pharmacia, 2000-2004
    • 46: Financial Analysis of Roche Products, 2000-2004
    • 47: Key Financial Ratios for Roche Products, 2000-2004
    • 48: Financial Analysis of Shire Pharmaceuticals Group, 2000-2004
    • 49: Key Financial Ratios for Shire Pharmaceuticals Group, 2000-2004
    • 50: Financial Analysis of Unichem, 2000-2004
    • 51: Key Financial Ratios for Unichem, 2000-2004
    • 52: Financial Analysis of 3m Health Care, 2000-2004
    • 53: Key Financial Ratios for 3m Health Care, 2000-2004
    • 54: Forecast UK Apparent Consumption for Pharmaceutical Products, 2006-2010
    • 55: Forecast UK Market for Pharmaceutical Products, 2006-2010
    • 56: Forecast Segmentation of UK Apparent Consumption of Pharmaceutical Products 2006-2010
    • 57: Forecast Segmentation of The UK Market for Pharmaceutical Products, 2006-2010
+44 20 8816 8548

Ask a question about UK Pharmaceutical Products Market Development Report

Enter the characters you see in the picture below
Captcha